Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,652.9
16.2 (0.62%)

 

  • STI Straits Times Index
    2,652.9
    16.2 (0.62%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,552.7
    16.4 (1.07%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,373.1
    248.9 (0.99%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,152.8
    62.2 (2.01%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,306.5
    160.5 (0.72%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,973.8
    7.0 (0.14%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,532.5M
  • Value: 907.4M
  • Rise: 181
  • Fall: 116
  • Unch: 511

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Medtecs Intl0.500+0.035
IPS Securex0.105+0.015
LionGold0.002-
Oceanus^0.007-
Secura0.094+0.003
Synagie0.191+0.012
ThaiBev0.695+0.020
Singapore-eDev0.115-0.001
New Wave0.011-0.001
Asian Micro0.004-

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,265.5 -284.5
HSCEI 9,743.2 -110.0
Jakarta 4,863.1 -41.0
Nikkei 225 22,047.8 -464.2
SSE Comp 2,960.5 -10.1
Shanghai A 3,103.1 -10.6
Shanghai B 211.8 -1.7
KOSPI 2,097.3 -37.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CIRC CIRC
Quotes 15 Minutes Delayed. Updated at 03 Jul 2020 16:05
Last (HKD): 22.450 Change: -0.450 High: 23.400 Remarks: -
Change (%): -1.97 Low: 22.350
Open 22.950 Yesterday's Close 22.900
Buy Price 22.500 Sell Price 22.650
Buy Volume ('000) 4.4 Sell Volume ('000) 1.4
Cumulative Volume ('000) 348.6 Cumulative Value 7,924,550
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 1.16637 Trailing EPS (HKD) e 1.16637 NAV (HKD) b 13.1464
PE a 19.248 Trailing PE f 19.248 Price / NAV b 1.7077
Dividend (HKD) d 0.152713 Cash In Hand (HKD) g 9.2724 Issued & Paid-up Shares c 79,968,800
Dividend Yield (%) d 0.680 Price / Cash In Hand g 2.421 Treasury Shares h -
Beta - 75 Daysi 0.580 R-Squared - 75 Days(%)i 20.96 Market Cap (M) 7,181.189
Beta - 500 Daysi 0.722 R-Squared - 500 Days (%)i 16.58 Enterprise Value (M) 6,491.707
Piotroski F Score 5 Exchange Code 1763 Par Value ( CNY ) 1.00000
52 Weeks Volatility (%) 32.65 6-Month VWAP 20.400 Free Float (%) 94.0
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 06 Aug 2018.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Jun 2018.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CIRC HKEx 7,181.189 19.248 19.248 1.7077 0.680
Industry Medical Specialties HKEx 17,397.612 110.636 110.636 6.6747 0.292
Local Peer WEIGAO GROUP HKEx 84,567.571 40.425 40.425 4.6710 0.709
Local Peer MICROPORT HKEx 64,890.360 178.944 178.948 16.0456 0.133
Local Peer KANGJI MEDICAL HKEx 36,940.195 178.940 178.936 112.8971 -
Local Peer VENUS MEDTECH-B HKEx 34,177.622 - - 10.0607 -
Local Peer AK MEDICAL HKEx 30,299.984 100.085 100.084 24.2727 0.261
Local Peer PEIJIA-B HKEx 21,930.609 - - -39.2857 -
Local Peer KDL MEDICAL HKEx 11,918.800 105.518 105.519 8.7597 0.272
Local Peer LIFETECH SCI HKEx 9,585.191 65.426 65.427 7.4385 -
Local Peer YESTAR HEALTH HKEx 2,827.395 12.303 12.303 2.1556 -
Local Peer PW MEDTECH HKEx 2,636.340 28.359 28.360 0.5114 -
Local Peer GOLDEN MEDITECH HKEx 2,362.713 - - 0.6145 -
Local Peer MODERN DENTAL HKEx 1,402.904 8.683 8.684 0.6942 3.654
Other Local Peers VINCENT MED (HKEx), YUNNAN ENERGY (HKEx), KELFRED (HKEx), LIFE HEALTHCARE (HKEx), HUAKANG BIOMED (HKEx)
Global Peer ABBOTT LABORATORIES NYSE 163,141.035 44.501 46.098 5.3988 1.426
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 144,508.621 39.099 39.386 5.0600 0.210
Global Peer DANAHER CORP NYSE 127,293.757 51.147 46.508 4.3216 0.372
Global Peer MEDTRONIC PLC NYSE 124,955.508 26.092 26.092 2.4628 2.318
Global Peer BECTON DICKINSON & CO NYSE 69,460.859 64.197 76.331 3.3157 1.207
Global Peer STRYKER CORP NYSE 68,945.862 33.099 31.860 5.2570 1.160
Global Peer INTUITIVE SURGICAL INC NASDAQ 67,694.417 49.079 48.831 7.9578 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 50,548.467 10.755 11.791 3.6619 -
Global Peer BAXTER INTERNATIONAL INC NYSE 44,375.588 44.331 43.463 5.7638 0.970
Global Peer EDWARDS LIFESCIENCES CORP NYSE 42,874.552 40.954 38.702 10.9904 -
Other Global Peers KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), DEXCOM INC (NASDAQ), ALCON AG (NYSE), IDEXX LABORATORIES INC (NASDAQ), RESMED INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), BIO RAD LABORATORIES INC (NYSE), INSULET CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), STERIS PLC (NYSE), HARTA (Bursa), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), TOPGLOV (Bursa), Top Glove (SGX), WATERS CORP (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), PERKINELMER INC (NYSE), QIAGEN NV (NYSE), DENTSPLY SIRONA INC (NASDAQ), QUIDEL CORP (NASDAQ), COCHLEAR LTD (ASX), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), BRUKER CORPORATION (NASDAQ), NOVOCURE LTD (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), GLOBUS MED INC (NYSE), HAEMONETICS CORP (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEOGEN CORP (NASDAQ), NEVRO CORP (NYSE), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), INOVIO PHARMACEUTICALS INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), NUVASIVE INC (NASDAQ), SUPERMX (Bursa), STAAR SURGICAL CO (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), LIVANOVA PLC (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), INARI MEDICAL INC (NASDAQ), EBOS GROUP (ASX), CONMED CORP (NYSE), ATRICURE INC (NASDAQ), CANTEL MEDICAL CORP (NYSE), GLAUKOS CORPORATION (NYSE), CAREDX INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), AVANOS MEDICAL INC (NYSE), NANOSONICS LIMITED (ASX), SILK ROAD MEDICAL INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), VAPOTHERM INC (NYSE), INMODE LTD (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), HESKA CORP (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), ZYNEX INC (NASDAQ), INOGEN INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), CRYOLIFE INC (NYSE), VERICEL CORP (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), TRANSMEDICS GROUP INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SI BONE INC (NASDAQ), AXOGEN INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), CORMEDIX INC (NYSE American), CYTOSORBENTS CORP (NASDAQ), VIEWRAY INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), MEDICAL DEVELOPMENT INTL (ASX), ALPHATEC HLDGS INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), STEREOTAXIS INC (NYSE American), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), IRADIMED CORP (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), PROFOUND MED CORP (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ALPHA PRO TECH (NYSE American), MISONIX INC (NASDAQ), INVACARE CORP (NYSE), RTI SURGICAL HOLDINGS INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), CUTERA INC (NASDAQ), DERMTECH INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), SIENTRA INC (NASDAQ), Medtecs Intl (SGX), TELA BIO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), UG Healthcare (SGX), APYX MEDICAL CORPORATION (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), SOLITON INC (NASDAQ), FONAR CORP (NASDAQ), CELSION CORPORATION (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ELECTROMED INC (NYSE American), BELLEROPHON THERAPEUTICS INC (NASDAQ), INTRICOM CORP (NASDAQ), VENUS CONCEPT INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), PAVMED INC (NASDAQ), BIOMERICA INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), CYCLOPHARM LIMITED (ASX), SOMNOMED LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), NEPHROS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), DAXOR CORP (NYSE American), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), LKL (Bursa), Biolidics (SGX), SDI LTD (ASX), CLEARPOINT NEURO INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), CONFORMIS INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), IMPEDIMED LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), DIMERIX LTD (ASX), SENSUS HEALTHCARE INC (NASDAQ), ONCOCYTE CORP (NYSE American), COMPUMEDICS (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), RESONANCE HEALTH LTD (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), RESPIRI LTD (ASX), MOTUS GI HOLDINGS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), IMMUCELL CORP (NASDAQ), NEOVASC INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), NEURONETICS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), Yunnan Energy (SGX), MICRO-X LTD (ASX), ELECTROCORE INC (NASDAQ), LBT INNOVATIONS LTD (ASX), IRIDEX CORP (NASDAQ), IMPRESSION HEALTHCARE LIMITED (ASX), METALICITY LIMITED (ASX), NEUROTROPE INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), USCOM LTD (ASX), DARIOHEALTH CORP (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), BIOLASE INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), AETHLON MEDICAL INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), IMAGION BIOSYSTEMS LIMITED (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), CHECK-CAP LTD (NASDAQ), AVINGER INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), ENDOLOGIX INC (NASDAQ), CYANOTECH CORP (NASDAQ), OPTISCAN IMAGING (ASX), DIGIRAD CORP (NASDAQ), CARDIEX LTD (ASX), DYNATRONICS CORP (NASDAQ), Annica (SGX), ADHERIUM LIMITED (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), CANCER GENETICS INC (NASDAQ), ANALYTICA (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), DORSAVI LTD (ASX), NEUROMETRIX INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.850
+3.94 %
10 Days -+0.850
+3.94 %
20 Days -+3.190
+16.56 %
Medium Term Return 3 Months -+5.350
+31.29 %
6 Months -+1.450
+6.90 %
1 Year -+4.050
+22.01 %
Long Term Return 2 Years 0.309+2.350
+13.23 %
Annualised Return Annualised --
+6.41 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 16.220 - 24.600 Change From 1 Year Low +6.230 % Change From 1 Year Low (%) +38.41
Change From 1 Year High -2.150 % Change From 1 Year High (%) -8.74
2 Years Range 12.700 - 24.600 Change From 2 Years Low +9.750 % Change From 2 Years Low (%) +76.77
Change From 2 Years High -2.150 % Change From 2 Years High (%) -8.74
5 Years Range 12.700 - 24.600 Change From 5 Years Low +9.750 % Change From 5 Years Low (%) +76.77
Change From 5 Years High -2.150 % Change From 5 Years High (%) -8.74
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

China Isotope & Radiation Corp. engages in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications. It also offers irradiation service for sterilization purpose and EPC service for the design, manufacturing and installation of gamma ray irradiation facilities, independent clinical laboratory services to hospitals and other medical institutions. The company has following four business segments: Pharmaceuticals, Radioactive source products, irradiation, independent clinical laboratory services and other businesses. China Isotope & Radiation was founded in 1983 and is headquartered in Beijing, China.

Historical Price Data

Date Open High Low Close Volume VWAP
03 Jul 2020 22.950 23.400 22.350 22.450 348,600 22.7325
02 Jul 2020 22.600 23.200 22.300 22.900 599,400 22.8741
30 Jun 2020 22.100 22.600 21.800 22.200 748,600 22.1822
29 Jun 2020 21.450 22.150 21.450 22.100 2,071,600 21.9984
26 Jun 2020 21.500 22.000 21.500 21.600 72,605 21.5884
24 Jun 2020 21.500 21.800 21.150 21.550 287,492 21.6502
23 Jun 2020 21.800 22.150 21.750 21.750 652,800 21.9809
22 Jun 2020 21.600 22.350 21.600 22.100 1,346,935 22.0354
19 Jun 2020 21.750 21.800 21.500 21.600 155,800 21.5178
18 Jun 2020 22.000 22.000 21.350 21.500 94,600 21.4501
17 Jun 2020 21.600 22.400 21.350 21.800 451,700 21.9385
16 Jun 2020 21.400 22.300 21.100 21.600 189,000 21.5660
15 Jun 2020 21.050 21.750 21.050 21.050 100,200 21.4002
12 Jun 2020 20.700 22.200 20.700 21.500 187,766 21.5919
11 Jun 2020 20.800 22.250 20.800 21.450 418,400 21.6254
10 Jun 2020 20.300 21.800 20.300 21.200 311,300 21.2683
09 Jun 2020 20.000 20.400 19.640 20.250 140,449 20.1675
08 Jun 2020 19.500 20.900 19.500 19.960 235,800 20.2100
05 Jun 2020 18.940 19.260 18.940 19.260 28,400 19.2225
04 Jun 2020 19.200 19.360 18.880 19.220 129,800 19.1673
03 Jun 2020 19.180 19.180 18.680 19.040 66,600 18.8423
02 Jun 2020 19.200 19.320 18.560 18.660 110,500 18.9012
Summary
Current 2 Weeks
(18 Jun 2020 to 03 Jul 2020)
22.000 23.400 21.150 22.450 6,378,432 -
Previous 2 Weeks
(04 Jun 2020 to 17 Jun 2020)
19.200 23.400 18.880 21.800 2,192,815 -
4 Weeks from
(07 May 2020 to 03 Jun 2020)
16.460 23.400 16.460 19.040 5,604,711 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.